OpenURL Connection Search

Select item for more details and to access through your institution.

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset.
Published in:
Japanese Journal of Clinical Oncology, 2018, v. 48, n. 4, p. 367, doi. 10.1093/jjco/hyy016
By:
- Katsuyuki Kiura;
- Fumio Imamura;
- Hiroshi Kagamu;
- Shingo Matsumoto;
- Toyoaki Hida;
- Kazuhiko Nakagawa;
- Miyako Satouchi;
- Isamu Okamoto;
- Mitsuhiro Takenoyama;
- Yasuhito Fujisaka;
- Takayasu Kurata;
- Masayuki Ito;
- Kota Tokushige;
- Hatano, Ben;
- Makoto Nishio
Publication type:
Article
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors.
Published in:
Investigational New Drugs, 2015, v. 33, n. 5, p. 1058, doi. 10.1007/s10637-015-0270-2
By:
- Kasuga, Akiyoshi;
- Nakagawa, Kazuhiko;
- Nagashima, Fumio;
- Shimizu, Toshio;
- Naruge, Daisuke;
- Nishina, Shinichi;
- Kitamura, Hiroshi;
- Kurata, Takayasu;
- Takasu, Atsuko;
- Fujisaka, Yasuhito;
- Okamoto, Wataru;
- Nishimura, Yuichiro;
- Mukaiyama, Akihira;
- Matsushita, Hideki;
- Furuse, Junji
Publication type:
Article
Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors.
Published in:
Investigational New Drugs, 2015, v. 33, n. 2, p. 380, doi. 10.1007/s10637-014-0196-0
By:
- Fujisaka, Yasuhito;
- Kurata, Takayasu;
- Tanaka, Kaoru;
- Kudo, Toshihiro;
- Okamoto, Kunio;
- Tsurutani, Junji;
- Kaneda, Hiroyasu;
- Okamoto, Isamu;
- Namiki, Masayuki;
- Kitamura, Chifumi;
- Nakagawa, Kazuhiko
Publication type:
Article
Inhibition of EGFR, HER2 and HER3 signaling with AZD8931 alone and in combination with paclitaxel: Phase I study in Japanese patients with advanced solid malignancies and advanced breast cancer.
Published in:
Investigational New Drugs, 2014, v. 32, n. 5, p. 946, doi. 10.1007/s10637-014-0112-7
By:
- Kurata, Takayasu;
- Tsurutani, Junji;
- Fujisaka, Yasuhito;
- Okamoto, Wataru;
- Hayashi, Hidetoshi;
- Kawakami, Hisato;
- Shin, Eisei;
- Hayashi, Nobuya;
- Nakagawa, Kazuhiko
Publication type:
Article
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).
Published in:
International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 79, doi. 10.1007/s10147-022-02266-x
By:
- Katakami, Nobuyuki;
- Yokoyama, Toshihide;
- Morita, Satoshi;
- Okamoto, Tatsuro;
- Urata, Yoshiko;
- Hattori, Yoshihiro;
- Iwamoto, Yasuo;
- Sato, Yuki;
- Ikeda, Norihiko;
- Takahashi, Toshiaki;
- Daga, Haruko;
- Oguri, Tetsuya;
- Fujisaka, Yasuhito;
- Nishino, Kazumi;
- Sugawara, Shunichi;
- Kozuki, Toshiyuki;
- Oki, Masahide;
- Yamamoto, Nobuyuki;
- Nakagawa, Kazuhiko
Publication type:
Article
Details of Cancer Education Programs for Adolescents and Young Adults and Their Effectiveness: A Scoping Review.
Published in:
Journal of Adolescent & Young Adult Oncology, 2023, v. 12, n. 1, p. 9, doi. 10.1089/jayao.2021.0160
By:
- Suzuki, Kumi;
- Yamanaka, Masako;
- Minamiguchi, Yoko;
- Hayashi, Naoko;
- Yamauchi, Eiko;
- Fukawa, Akiko;
- Tsuda, Yasuhiro;
- Fujisaka, Yasuhito;
- Doi, Tomoki;
- Shiino, Ikue;
- Tomari, Yuko
Publication type:
Article
First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours.
Published in:
Investigational New Drugs, 2013, v. 31, n. 1, p. 108, doi. 10.1007/s10637-012-9809-7
By:
- Fujisaka, Yasuhito;
- Onozawa, Yusuke;
- Kurata, Takayasu;
- Yasui, Hirofumi;
- Goto, Isao;
- Yamazaki, Kentaro;
- Machida, Nozomu;
- Watanabe, Junichiro;
- Shimada, Hitoshi;
- Shi, Xiaojin;
- Boku, Narikazu
Publication type:
Article
Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments.
Published in:
2021
By:
- Sase, Kazuhiro;
- Fujisaka, Yasuhito;
- Shoji, Masaaki;
- Mukai, Mikio
Publication type:
journal article
Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days.
Published in:
Cancer Science, 2005, v. 96, n. 10, p. 721, doi. 10.1111/j.1349-7006.2005.00109.x
By:
- Yamada, Yasuhide;
- Yamamoto, Noboru;
- Shimoyama, Tatsu;
- Horiike, Atsushi;
- Fujisaka, Yasuhito;
- Takayama, Kyoko;
- Sakamoto, Terumi;
- Nishioka, Yuki;
- Yasuda, Sanae;
- Tamura, Tomohide
Publication type:
Article
A Phase 1 Clinical Study of Temsirolimus (CCI-779) in Japanese Patients with Advanced Solid Tumors.
Published in:
Japanese Journal of Clinical Oncology, 2010, v. 40, n. 8, p. 732, doi. 10.1093/jjco/hyq047
By:
- Fujisaka, Yasuhito;
- Yamada, Yasuhide;
- Yamamoto, Noboru;
- Horiike, Atsushi;
- Tamura, Tomohide
Publication type:
Article
Phase I and Pharmacokinetic Study of HER2-targeted rhuMAb 2C4 (Pertuzumab, RO4368451) in Japanese Patients with Solid Tumors.
Published in:
Japanese Journal of Clinical Oncology, 2009, v. 39, n. 4, p. 260, doi. 10.1093/jjco/hyp006
By:
- Yamamoto, Noboru;
- Yamada, Yasuhide;
- Fujiwara, Yutaka;
- Yamada, Kazuhiko;
- Fujisaka, Yasuhito;
- Shimizu, Toshio;
- Tamura, Tomohide
Publication type:
Article
Phase I Study of Cisplatin Analogue Nedaplatin, Paclitaxel, and Thoracic Radiotherapy for Unresectable Stage III Non-Small Cell Lung Cancer.
Published in:
Japanese Journal of Clinical Oncology, 2007, v. 37, n. 3, p. 175, doi. 10.1093/jjco/hym008
By:
- Sekine, Ikuo;
- Sumi, Minako;
- Ito, Yoshinori;
- Kato, Terufumi;
- Fujisaka, Yasuhito;
- Nokihara, Hiroshi;
- Yamamoto, Noboru;
- Kunitoh, Hideo;
- Ohe, Yuichiro;
- Tamura, Tomohide
Publication type:
Article
Phase 1 Clinical Study of Pegylated Liposomal Doxorubicin (JNS002) in Japanese Patients with Solid Tumors.
Published in:
Japanese Journal of Clinical Oncology, 2006, v. 36, n. 12, p. 768, doi. 10.1093/jjco/hyl109
By:
- Fujisaka, Yasuhito;
- Horiike, Atsushi;
- Shimizu, Toshio;
- Yamamoto, Noboru;
- Yamada, Yasuhide;
- Tamura, Tomohide
Publication type:
Article
Pharmacokinetics and Pharmacodynamics of Weekly Epoetin Beta in Lung Cancer Patients.
Published in:
Japanese Journal of Clinical Oncology, 2006, v. 36, n. 8, p. 477, doi. 10.1093/jjco/hyl074
By:
- Fujisaka, Yasuhito;
- Tamura, Tomohide;
- Ohe, Yuichiro;
- Kunitoh, Hideo;
- Sekine, Ikuo;
- Yamamoto, Noboru;
- Nokihara, Hiroshi;
- Horiike, Atsushi;
- Kodama, Tetsuro;
- Saijo, Nagahiro
Publication type:
Article
An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumors.
Published in:
2018
By:
- Furuse, Junji;
- Okano, Naohiro;
- Naruge, Daisuke;
- Kitamura, Hiroshi;
- Nagashima, Fumio;
- Kurata, Takayasu;
- Fujisaka, Yasuhito;
- Shimizu, Toshio;
- Iwasa, Tsutomu;
- Nakagawa, Kazuhiko
Publication type:
journal article
Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 5, p. 935, doi. 10.1007/s00280-010-1243-y
By:
- Fujisaka, Yasuhito;
- Yamada, Yasuhide;
- Yamamoto, Noboru;
- Shimizu, Toshio;
- Fujiwara, Yutaka;
- Yamada, Kazuhiko;
- Tamura, Tomohide;
- Watanabe, Hiroyuki;
- Yu-Nien Sun;
- Bass, Michael B.;
- Seki, Mitsuo
Publication type:
Article
Phase I clinical and pharmacokinetic study of 3-weekly, 3-h infusion of ixabepilone (BMS-247550), an epothilone B analog, in Japanese patients with refractory solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 5, p. 751, doi. 10.1007/s00280-007-0530-8
By:
- Shimizu, Toshio;
- Yamamoto, Noboru;
- Yamada, Yasuhide;
- Fujisaka, Yasuhito;
- Yamada, Kazuhiko;
- Fujiwara, Yutaka;
- Takayama, Kyoko;
- Tokudome, Takuto;
- Klimovsky, Judith;
- Tamura, Tomohide
Publication type:
Article
Phase I dose-finding and pharmacokinetic study of the oral epidermal growth factor receptor tyrosine kinase inhibitor Ro50-8231 (erlotinib) in Japanese patients with solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 489, doi. 10.1007/s00280-007-0494-8
By:
- Yamamoto, Noboru;
- Horiike, Atsushi;
- Fujisaka, Yasuhito;
- Murakami, Haruyasu;
- Shimoyama, Tatsu;
- Yamada, Yasuhide;
- Tamura, Tomohide
Publication type:
Article
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab.
Published in:
Science Translational Medicine, 2011, v. 3, n. 99, p. 1, doi. 10.1126/scitranslmed.3002442
By:
- Yonesaka, Kimio;
- Zejnullahu, Kreshnik;
- Okamoto, Isamu;
- Satoh, Taroh;
- Cappuzzo, Federico;
- Souglakos, John;
- Ercan, Dalia;
- Rogers, Andrew;
- Roncalli, Massimo;
- Takeda, Masayuki;
- Fujisaka, Yasuhito;
- Philips, Juliet;
- Shimizu, Toshio;
- Maenishi, Osamu;
- Yonggon Cho;
- Sun, Jason;
- Destro, Annarita;
- Taira, Koichi;
- Takeda, Koji;
- Okabe, Takafumi
Publication type:
Article
Large Cell Neuroendocrine Carcinoma of the Lung withCancer-Associated Retinopathy.
Published in:
Case Reports in Oncology, 2015, v. 8, n. 1, p. 153, doi. 10.1159/000380943
By:
- Nakamura, Takahiko;
- Fujisaka, Yasuhito;
- Tamura, Yosuke;
- Tsuji, Hiroyuki;
- Matsunaga, Ninso;
- Yoshida, Shuhei;
- Imanishi, Masafumi;
- Fujita, Kazuhiko;
- Ikeda, Soichiro;
- Oku, Hidehiro;
- Goto, Isao;
- Ikeda, Tsunehiko;
- Hanafusa, Toshiaki
Publication type:
Article
Cancer awareness and its related factors among junior high and high school teachers in Japan: a cross-sectional survey.
Published in:
Archives of Public Health, 2024, v. 82, n. 1, p. 1, doi. 10.1186/s13690-024-01292-7
By:
- Suzuki, Kumi;
- Hayashi, Naoko;
- Yamanaka, Masako;
- Minamiguchi, Yoko;
- Yamauchi, Eiko;
- Fukawa, Akiko;
- Tsuda, Yasuhiro;
- Fujisaka, Yasuhito;
- Doi, Tomoki;
- Tomari, Yuko
Publication type:
Article
Phase I/II Study of Cisplatin plus Nab‐Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non‐Small Cell Lung Cancer.
Published in:
Oncologist, 2021, v. 26, n. 1, p. 19, doi. 10.1002/ONCO.13524
By:
- Hayashi, Hidetoshi;
- Ogura, Masakazu;
- Niwa, Takashi;
- Yokoyama, Toshihide;
- Tanizaki, Junko;
- Ozaki, Tomohiro;
- Yoshioka, Hiroshige;
- Kurata, Takayasu;
- Tamura, Yosuke;
- Fujisaka, Yasuhito;
- Tanaka, Kaoru;
- Hasegawa, Yoshikazu;
- Kudo, Keita;
- Chiba, Yasutaka;
- Nakagawa, Kazuhiko
Publication type:
Article
The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting.
Published in:
Oncology Letters, 2023, v. 26, n. 6, p. N.PAG, doi. 10.3892/ol.2023.14108
By:
- Fujisaka, Yasuhito;
- Nakagawa, Takatoshi;
- Tomoda, Kiichiro;
- Watanabe, Marina;
- Matsunaga, Ninso;
- Tamura, Yosuke;
- Ikeda, Soichiro;
- Imagawa, Akihisa;
- Asahi, Michio
Publication type:
Article
Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual patient data from Japanese randomized, placebo-controlled trials.
Published in:
Cancer Science, 2013, v. 104, n. 4, p. 481, doi. 10.1111/cas.12105
By:
- Ohashi, Yasuo;
- Uemura, Yukari;
- Fujisaka, Yasuhito;
- Sugiyama, Toru;
- Ohmatsu, Hironobu;
- Katsumata, Noriyuki;
- Okamoto, Rumiko;
- Saijo, Nagahiro;
- Hotta, Tomomitsu
Publication type:
Article
Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor.
Published in:
Cancer Science, 2013, v. 104, n. 1, p. 98, doi. 10.1111/cas.12034
By:
- Hayashi, Hidetoshi;
- Kurata, Takayasu;
- Fujisaka, Yasuhito;
- Kawakami, Hisato;
- Tanaka, Kaoru;
- Okabe, Takafumi;
- Takeda, Masayuki;
- Satoh, Taroh;
- Yoshida, Koji;
- Tsunoda, Takuya;
- Arao, Tokuzo;
- Nishio, Kazuto;
- Nakagawa, Kazuhiko
Publication type:
Article

Found: 25